Tamoxifen Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Conditions:   Breast Atypical Hyperplasia;   Breast Carcinoma;   Breast Ductal Carcinoma In Situ;   Breast Lobular Carcinoma In Situ Interventions:   Drug: Acolbifene Hydrochloride;   Procedure: Biospecimen Collection;   Procedure: Mammography;   Procedure: Random Periareolar Fine-Needle Aspiration;   Drug: Tamoxifen Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials